Translational radiopharmaceutical sciences

SCHOTTELIUS Lab

Within the framework of a KFS-funded (2021-2023) project (“RADIATION”), which is centered on the development of radiolabeled Diabodies for molecular imaging of distinct compartments of the tumor microenvironment of human tumors, Margret Schottelius' laboratory collaborates closely with the groups of: Dr Steven Dunn (Hi-TIDe : LAbCore immunoglobulin discovery and engineering: focus on diabody design), Pr Vincent Zoete (Computer-aided molecular engineering: focus on rational design of radiolabeling moieties) and Dr Melita Irving (Hi-TIDe : T cell engineering: focus on in vivo models for T-cell imaging). Another third-party funded collaborative project (“PREDICT”, San Salvatore foundation, 2021-2023) that aims to develop peptide-based radiotracers for imaging of immune checkpoint expression in vivo, is also built on the close interaction of Margret Schottelius' laboratory with those of Pr Vincent Zoete (in silico design and optimization of suitable peptide ligands) and Dr Melita Irving (in vivo models for T-cell imaging).

 

Visit Margret Schottelius' profile page @CHUV for more information. 

TOP ^

Follow us:  

CONTACT

Lausanne Oncology SCHOTTELIUS Lab.png

Margret SCHOTTELIUS
Ludwig adjunct scientist
Ludwig Institute for Cancer Research Lausanne

Associate Professor
Service of nuclear medicine and molecular imaging
Lausanne University Hospital

Ludwig Lausanne RGB-crop461x374.jpg (Print)

Phone +41 21 545 1120
Email

Ch. des Boveresses 155 - CH-1066 Epalinges
Switzerland
Tel. +41 21 692 59 92
Fax +41 21 692 59 95
Ludwig Cancer Research Université de Lausanne Centre Hospitalier Universitaire Vaudois (CHUV)